Shopping Cart
- Remove All
Your shopping cart is currently empty
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $32 | In Stock | |
| 2 mg | $46 | In Stock | |
| 5 mg | $77 | In Stock | |
| 10 mg | $128 | In Stock | |
| 25 mg | $257 | In Stock | |
| 50 mg | $383 | In Stock | |
| 100 mg | $533 | In Stock | |
| 200 mg | $737 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $88 | In Stock |
| Description | Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis. |
| Targets&IC50 | Hepsin:0.33 μM |
| In vitro | Hepln-13 (10 μM; 2 hours; 293 cells) inhibits cleavage[1]. |
| In vivo | HepIn-13 displays dose-dependent inhibition of Hepsin overexpression-relevant prostate cancer phenotypes in LPB-Tag/PB-Hepsin mice and blocks prostate cancer metastasis in this animal model. |
| Synonyms | Hepln13, Hepln 13 |
| Molecular Weight | 325.2 |
| Formula | C17H13BrN2 |
| Cas No. | 64369-13-7 |
| Smiles | Brc1ccc(cc1)C1Nc2cccc3cccc(N1)c23 |
| Relative Density. | 1.444g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (184.50 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.